Literature DB >> 2341839

Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.

S L Pullman1, R L Watts, J L Juncos, J N Sanes.   

Abstract

The effect of circulating levels of plasma levodopa on reaction time performance was studied in patients with Parkinson's disease and untreated normal controls when instructed to move either a shorter or longer distance. On half the movements, subjects were pre-cued on the direction and amplitude of an impending movement. On the remaining movements, only the direction was pre-specified, and the amplitude was determined only when the cue to move was presented. Reaction time performance of patients was evaluated at three infusion levels of levodopa so that the patients were optimally, moderately, or minimally medicated. Parkinsonian patients were always slower to react and move than normal subjects. Clinical state correlated with movement time, but not with reaction time. These results contrast with those in which reaction time was related to plasma levodopa levels when movement direction and initiation were processed concomitantly, but the movement amplitude was pre-cued. It is possible that specification of the amount of muscle activity is partially independent of dopaminergic transmission.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341839      PMCID: PMC1014163          DOI: 10.1136/jnnp.53.4.279

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  The preparation and production of isometric force in Parkinson's disease.

Authors:  G E Stelmach; C J Worringham
Journal:  Neuropsychologia       Date:  1988       Impact factor: 3.139

Review 2.  The representation of arm movements in postcentral and parietal cortex.

Authors:  J F Kalaska
Journal:  Can J Physiol Pharmacol       Date:  1988-04       Impact factor: 2.273

3.  Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

Authors:  S L Pullman; R L Watts; J L Juncos; T N Chase; J N Sanes
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

4.  Primate motor cortex and free arm movements to visual targets in three-dimensional space. I. Relations between single cell discharge and direction of movement.

Authors:  A B Schwartz; R E Kettner; A P Georgopoulos
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

5.  Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease.

Authors:  A Berardelli; J P Dick; J C Rothwell; B L Day; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

6.  The primate globus pallidus: neuronal activity related to direction of movement.

Authors:  S J Mitchell; R T Richardson; F H Baker; M R DeLong
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

7.  Movement preparation in Parkinson's disease. The use of advance information.

Authors:  G E Stelmach; C J Worringham; E A Strand
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

8.  Selective neuronal discharge in monkey putamen reflects intended direction of planned limb movements.

Authors:  G E Alexander
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

9.  Programming and execution of sequential movements in Parkinson's disease.

Authors:  R D Rafal; A W Inhoff; J H Friedman; E Bernstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

10.  Disturbance of sequential movements in patients with Parkinson's disease.

Authors:  R Benecke; J C Rothwell; J P Dick; B L Day; C D Marsden
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

View more
  9 in total

1.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment.

Authors:  J Harrison; L Henderson; C Kennard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

3.  Cognitive channels computing action distance and direction.

Authors:  R B Bhat; J N Sanes
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease.

Authors:  Ignacio Obeso; Leonora Wilkinson; Marjan Jahanshahi
Journal:  Exp Brain Res       Date:  2011-07-28       Impact factor: 1.972

5.  Coding of movement direction and amplitude in Parkinson's disease: are they differentially impaired (or unimportant)?

Authors:  D L Jones; J G Phillips; J L Bradshaw; R Iansek; J A Bradshaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

6.  Impaired anticipatory control of force sharing patterns during whole-hand grasping in Parkinson's disease.

Authors:  Lisa M Muratori; Tara L McIsaac; Andrew M Gordon; Marco Santello
Journal:  Exp Brain Res       Date:  2007-10-02       Impact factor: 1.972

7.  Cognitive slowing in Parkinson's disease resolves after practice.

Authors:  D Z Press; D J Mechanic; D Tarsy; D S Manoach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

8.  Focused and Sustained Attention Is Modified by a Goal-Based Rehabilitation in Parkinsonian Patients.

Authors:  Davide Ferrazzoli; Paola Ortelli; Roberto Maestri; Rossana Bera; Roberto Gargantini; Grazia Palamara; Marianna Zarucchi; Nir Giladi; Giuseppe Frazzitta
Journal:  Front Behav Neurosci       Date:  2017-03-31       Impact factor: 3.558

9.  Components determining the slowness of information processing in parkinson's disease.

Authors:  Aida Arroyo; José A Periáñez; Marcos Ríos-Lago; Genny Lubrini; Jorge Andreo; Julián Benito-León; Elan D Louis; Juan Pablo Romero
Journal:  Brain Behav       Date:  2021-01-15       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.